Liquidia Corp (LQDA)
12.74
+0.45
(+3.66%)
USD |
NASDAQ |
May 16, 16:00
12.72
-0.02
(-0.12%)
After-Hours: 20:00
Liquidia Price to Book Value: 11.28 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 16, 2024 | 11.28 |
May 15, 2024 | 10.88 |
May 14, 2024 | 10.59 |
May 13, 2024 | 10.75 |
May 10, 2024 | 10.68 |
May 09, 2024 | 11.05 |
May 08, 2024 | 11.07 |
May 07, 2024 | 11.37 |
May 06, 2024 | 11.24 |
May 03, 2024 | 11.33 |
May 02, 2024 | 11.49 |
May 01, 2024 | 11.66 |
April 30, 2024 | 11.38 |
April 29, 2024 | 11.04 |
April 26, 2024 | 11.10 |
April 25, 2024 | 10.94 |
April 24, 2024 | 11.10 |
April 23, 2024 | 11.45 |
April 22, 2024 | 11.66 |
April 19, 2024 | 11.75 |
April 18, 2024 | 12.21 |
April 17, 2024 | 12.26 |
April 16, 2024 | 12.01 |
April 15, 2024 | 12.10 |
April 12, 2024 | 12.34 |
Date | Value |
---|---|
April 11, 2024 | 13.56 |
April 10, 2024 | 13.12 |
April 09, 2024 | 13.23 |
April 08, 2024 | 13.38 |
April 05, 2024 | 13.89 |
April 04, 2024 | 13.53 |
April 03, 2024 | 13.58 |
April 02, 2024 | 13.60 |
April 01, 2024 | 13.20 |
March 31, 2024 | |
March 28, 2024 | 23.71 |
March 27, 2024 | 24.23 |
March 26, 2024 | 25.59 |
March 25, 2024 | 25.19 |
March 22, 2024 | 26.90 |
March 21, 2024 | 26.11 |
March 20, 2024 | 25.56 |
March 19, 2024 | 25.76 |
March 18, 2024 | 25.01 |
March 15, 2024 | 25.56 |
March 14, 2024 | 24.63 |
March 13, 2024 | 23.68 |
March 12, 2024 | 22.47 |
March 11, 2024 | 21.88 |
March 08, 2024 | 22.51 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.475
Minimum
Mar 29 2021
33.54
Maximum
Jul 06 2020
6.680
Average
4.533
Median
Oct 17 2019
Price to Book Value Benchmarks
United Therapeutics Corp | 2.259 |
AIM ImmunoTech Inc | 2.091 |
Perspective Therapeutics Inc | 11.98 |
Protalix BioTherapeutics Inc | 2.880 |
Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 54.00 |
PEG Ratio | -0.0457 |
Price | 12.74 |
Earnings Yield | -12.24% |
Market Cap | 971.97M |
PEGY Ratio | -0.0457 |